Riedel Norbert G

Riedel Norbert G is listed in filings as Director at Jazz Pharmaceuticals PLC. This profile follows SEC Form 4 activity through Apr 22, 2026, including sale activity. Recent filings connect the profile to Jazz Pharmaceuticals PLC (JAZZ), Eton Pharmaceuticals, Inc. (ETON), and Cerevel Therapeutics Holdings, Inc. (CERE). The current snapshot covers public activity from Aug 5, 2024 to Apr 22, 2026. Reported amounts are shown as $165.2K to $655.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.